Business
View from the C-Suite: Patrick McCutcheon, Chief Executive Officer, MediPharm Labs Corp., tells his company's story. Filmed on August 14, 2019
View from the C-Suite: Patrick McCutcheon, Chief Executive Officer, MediPharm Labs Corp., ...
About this update from Medipharm Labs Corp.
[{"type":"text","content":"\n\n\n\nView from the C-Suite: Patrick McCutcheon, Chief Executive Officer, MediPharm Labs Corp., tells his company's story. Filmed on August 14, 2019\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Aug. 27, 2019\n\n\n\nTORONTO, Aug. 27, 2019 /CNW/ -\n\n \n  \n\n \nhttps://www.youtube.com/watch?v=C6Vo5vR9g68 \nThe View from the C-Suite video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. Videos provide insight into how company executives think in the current business environment. To see the latest View from the C-Suite videos visit www.tmxmoney.com/en/news/csuite.html) \nAbout MediPharm Labs Corp. (TSX: LABS)\nFounded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical-like cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices designed facility and ISO standard built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines having 300,000 kg of annual processing capacity to deliver pure, safe and precisely-dosed cannabis products for its customers. Through its wholesale, white label and tolling platforms, they formulate, process, package and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, the Company also completed its first commercial export to Australia in June 2019 and is nearing completion of its Australian extraction facility expected in 2019 with 75,000 kg of annual processing capacity.\nAbout TMX Group (TSX: X)\nTMX Group's key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, The Canadian Depository for Securities, Montréal Exchange, Canadian Derivatives Clearing Cor...